Parag Doctor of Keynote Capital told CNBC-TV18, "Biocon has been our favourite for sometime on the long side. The stock has been making 52 week highs. The other pharma stocks have taken a breather but Biocon still continues to breakout after it took out Rs 330 resistance.'
He further added, "We expect it to go towards Rs 360 mark or so and probably it could happen in this week itself and the stoploss for the trade at Rs 339. Those who are positional traders probably could keep a stop around Rs 330 mark or so." Also Read: Drug pricing policy issue hurting sector's growth: Biocon Disclosures: I don't have any personal position, we may have recommended to our clients.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
